Utility of prognostic prediction by early assessment of response to combined treatment with nivolumab plus ipilimumab in patients with treatment-naïve metastatic renal cell carcinoma.
Ken-Ichi HaradaHideaki MiyakeJunya FurukawaNaohiro FujimotoMasato FujisawaPublished in: International journal of urology : official journal of the Japanese Urological Association (2023)